Product Datasheet
p21 Antibody
Catalog Number: 35343
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:P38936;
NCBI Gene#:1026
- Form of Antibody:
- Rabbit IgG in 1XPBS, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
- Immunogen:
- Recombinant fragment corresponding to a region within amino acids 1 and 164 of p21.
- appl_detail:
- Western blotting: 1:500-1:3000
Immunofluorescence: 1:100-1:1000
- other_names:
- CAP20 antibody; CDKN1 antibody; CIP1 antibody; MDA-6 antibody; P21 antibody; SDI1 antibody; WAF1 antibody; p21CIP1 antibody; CDKN1A antibody; cyclin-dependent kinase inhibitor 1 antibody; melanoma differentiation associated protein 6 antibody; wild-type p
- Purification:
- Antibodies were purified by antigen-affinity chromatography.
- Specificity:
- The antibody detects endogenous levels of total p21 protein.
- Background:
- This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen (PCNA), a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported. [provided by RefSeq]
© Signalway Biotechnology All Rights Reserved.